Given these evidences, the miR-139-5p-GALNT2-LATS2 axis is critical for RCC proliferation, and it is an excellent candidate for a new therapeutic target in ccRCC. This evidence concerns the gene GALNT2 and nonpapillary renal cell carcinoma.